A Study to Evaluate the Drug Levels, Efficacy, and Safety of Deucravacitinib (BMS-986165) in Pediatric Participants With Juvenile Psoriatic Arthritis

PHASE3RecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

March 13, 2025

Primary Completion Date

March 6, 2030

Study Completion Date

March 4, 2031

Conditions
Juvenile Psoriatic Arthritis
Interventions
DRUG

Deucravacitinib

Specified dose on specified days

OTHER

Placebo

Specified dose on specified days

Trial Locations (42)

1797

NOT_YET_RECRUITING

Local Institution - 0062, Sofia

4002

RECRUITING

"University Multiprofile Hospital for Active Treatment Sveti Georgi EAD", Plovdiv

11040

NOT_YET_RECRUITING

Local Institution - 0059, North New Hyde Park

22081

RECRUITING

Praxis Kinder- und Jugendrheumatologie Dr. Ivan Foeldvari, Hamburg

28034

RECRUITING

Hospital Universitario Ramón y Cajal, Madrid

30625

NOT_YET_RECRUITING

Local Institution - 0025, Hanover

34098

NOT_YET_RECRUITING

Local Institution - 0043, Istanbul- Fatih

34766

NOT_YET_RECRUITING

Local Institution - 0045, Istanbul

44109

NOT_YET_RECRUITING

Local Institution - 0066, Cleveland

45229

NOT_YET_RECRUITING

Local Institution - 0065, Cincinnati

46026

RECRUITING

Hospital Universitari i Politecnic La Fe, Valencia

46202

NOT_YET_RECRUITING

Local Institution - 0023, Indianapolis

50139

RECRUITING

Azienda Ospedaliera Universitaria Meyer IRCCS, Florence

60611

NOT_YET_RECRUITING

Local Institution - 0020, Chicago

78723

NOT_YET_RECRUITING

Local Institution - 0036, Austin

80131

RECRUITING

University of Naples Federico II, Napoli

91054

RECRUITING

Kinderklinik des Uni-Klinikums Erlangen, Erlangen

93534

NOT_YET_RECRUITING

Local Institution - 0038, Lancaster

100045

NOT_YET_RECRUITING

Local Institution - 0049, Beijing

130000

NOT_YET_RECRUITING

Local Institution - 0053, Changchun

200032

NOT_YET_RECRUITING

Local Institution - 0050, Shanghai

210008

NOT_YET_RECRUITING

Local Institution - 0052, Nanjing

247065

RECRUITING

Sc Medaudio-Optica Srl, Râmnicu Vâlcea

310003

NOT_YET_RECRUITING

Local Institution - 0051, Hangzhou

400065

NOT_YET_RECRUITING

Local Institution - 0056, Chongqing

400177

RECRUITING

Spitalul Clinic de Urgenta pentru Copii Cluj-Napoca, Cluj-Napoca

510620

NOT_YET_RECRUITING

Local Institution - 0060, Guangzhou

700135

WITHDRAWN

Local Institution - 0048, Iași

78020-500

WITHDRAWN

Local Institution - 0032, Cuiabá

30150-221

NOT_YET_RECRUITING

Local Institution - 0030, Belo Horizonte

50670-420

NOT_YET_RECRUITING

Local Institution - 0007, Recife

90020-090

NOT_YET_RECRUITING

Local Institution - 0033, Porto Alegre

90480-000

NOT_YET_RECRUITING

Local Institution - 0008, Porto Alegre

21941-612

NOT_YET_RECRUITING

Local Institution - 0027, Rio de Janeiro

01223-001

NOT_YET_RECRUITING

Local Institution - 0047, São Paulo

04022-001

WITHDRAWN

Local Institution - 0010, São Paulo

779 00

RECRUITING

Fakultni nemocnice Olomouc, Olomouc

150 06

RECRUITING

Fakultni nemocnice v Motole, Prague

00917

NOT_YET_RECRUITING

Local Institution - 0017, San Juan

08035

RECRUITING

Hospital Universitari Vall d'Hebron, Barcelona

06170

NOT_YET_RECRUITING

Local Institution - 0061, Ankara

06230

NOT_YET_RECRUITING

Local Institution - 0044, Ankara

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY

NCT06869551 - A Study to Evaluate the Drug Levels, Efficacy, and Safety of Deucravacitinib (BMS-986165) in Pediatric Participants With Juvenile Psoriatic Arthritis | Biotech Hunter | Biotech Hunter